Are you a new member? Sign up now
Login area
| Sign up
close
ARKANDA 8 - 8mg - 30
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C09CA06 | G | Candesartan cilexetil - 8mg | 11274 | 129222/1 | ARKANDA 8 | 8mg | 30 | Tablet | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 639,925 L.L | 23.08 | A1 | 2/5/2024 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C09CA06 | B | Candesartan cilexetil - 8mg | 11219 | 87421/1 | ATACAND | 8mg | 28 | Tablet | Oral | Omnipharma | AstraZeneca AB | Sweden | 807,649 L.L | 23.08 | A2 | AstraZeneca AG | Switzerland | 2/5/2024 | 0 |
| C09CA06 | B | Candesartan cilexetil - 8mg | 1381 | 405698/00 | BLOPRESS | 8mg | 28 | Tablet | Oral | Abela Frères S.A.L. | The Arab Pharmaceutical Manufacturing PSC (APM) under license from Takeda Pharmaceutical company Ltd Japan | Jordan | 847,965 L.L | 23.08 | A2 | 2/5/2024 | 0 | ||
| C09CA06 | G | Candesartan cilexetil - 8mg | 6823 | 218834/09 | ANDESART 8 | 8mg | 30 | Tablet | Oral | C. Catafago & Co | The Jordanian Pharmaceutical Manufacturing Co. (JPM) | Jordan | 498,566 L.L | 23.08 | A1 | The Jordanian Pharmaceutical Manufacturing & Co Ltd | Jordan | 2/5/2024 | 0 |
| C09CA06 | G | Candesartan cilexetil - 8mg | 10111 | 83018/1 | CANDESARTAN BIOGARAN | 8mg | 30 | Tablet, scored | Oral | Commercial and Trading Ressources SAL (CTR) | Bluepharma Industria Farmaceutica SA | Portugal | 434,061 L.L | 23.08 | A1 | Laboratoires Biogaran | France | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024